Multi-omics and Alzheimer’s disease: a slower but surer path to an efficacious therapy?

alzheimer’s disease (AD) is a slowly progressing neurodegenerative disorder of complex, and as yet uncertain, etiology. With a rapidly aging population in Western societies, AD poses a significant burden on resources. Because of the increasing threat it poses to healthcare systems, AD has been a